Five top executives at US biotech firm Moderna, including its Israeli chief medical officer, have cashed out stocks worth $89 million this year as shares in the company soared after it reported succe⦠[+8027 chars]Source
Five top executives at US biotech firm Moderna, including its Israeli chief medical officer, have cashed out stocks worth $89 million this year as shares in the company soared after it reported succe⦠[+8027 chars]Source
